A common CD4 gene variant is associated with an increased risk of HIV-1 infection in kenyan female commercial sex workers

Journal of Infectious Diseases

Volumn 199, Issue 9, 2009, Pages 1327-1334

  Oyugi, Julius O ^a   Vouriot, Françoise C M ^a   Alimonti, Judie ^c   Wayne, Stephen ^a   Luo, Ma ^a   Land, Allison M ^a   Ao, Zhujun ^a   Yao, Xiaojian ^a   Sekaly, Rafick P ^d   Elliott, Lawrence J ^b   Simonsen, J Neil ^c   Ball, T Blake ^a,e   Jaoko, Walter ^e   Kimani, Joshua ^e   Plummer, Francis A ^a,b,c   Fowke, Keith R ^a,b,e,f  

^a Departments of Medical Microbiology   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA ISOLATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; KENYA; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS ISOLATION;

EID: 65649092046     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597616     Document Type: Article

References (35)

1. Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96:4581-5.
2. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240-3.
3. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-5.
4. Cohen OJ, Paolucci S, Bende SM, et al. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32. J Virol 1998; 72:6215-7.
5. Cargill M, Altshuler D, Ireland J, et al. Characterization of singlenucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-8.
6. Wenkert D, Schoneberg T, Merendino JJ Jr, et al. Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol 1996; 124:43-50.
7. Lisa A, Astolfi P, Degioanni A, Di Pasquale C, Zei G. Differential fertility as a mechanism maintaining balanced polymorphisms in Sardinia. Hum Biol 1994; 66:683-98.
8. Angadi CV. Lack of Leu-3a epitope on T-helper (CD4) lymphocytes. J Clin Lab Anal 1990; 4:193-5.
9. Indraccolo S, Mion M, Biagiotti R, et al. Genetic variability of the human CD4 V2 domain. Immunogenetics 1996; 44:70-2.
10. Neuhuber F, Radacher M, Krasa B. F13B and CD4 allele frequencies in an Austrian population sample. Int J Legal Med 1996; 108:227.
11. Bach MA, Phan-Dinh-Tuy F, Bach JF, et al. Unusual phenotypes of human inducer T cells as measured by OKT4 and related monoclonal antibodies. J Immunol 1981; 127:980-2.
12. Lederman S, DeMartino JA, Daugherty BL, et al. A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol 1991; 28: 1171-81.
13. Fuller TC, Trevithick JE, Fuller AA, Colvin RB, Cosimi AB, Kung PC. Antigenic polymorphism of the T4 differentiation antigen expressed on human T helper/inducer lymphocytes. Hum Immunol 1984; 9:89-102.
14. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 1985; 42:93-104.
15. Hodge TW, Sasso DR, McDougal JS. Humans with OKT4-epitope deficiency have a single nucleotide base change in the CD4 gene, resulting in substitution of TRP240 for ARG240. Hum Immunol 1991; 30:99-104.
16. Matthias LJ, Yam PT, Jiang XM, et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 2002; 3:727-32.
17. Fleury S, Lamarre D, Meloche S, et al. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 1991; 66:1037-49.
18. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347.
19. Simonsen JN, Fowke KR, MacDonald KS, Plummer FA. HIV pathogenesis: mechanisms of susceptibility and disease progression. Curr Opin Microbiol 1998; 1:423-9.
20. Land AM, Ball TB, Luo M, et al. Full-length HIV-1 proviral sequencing of ten highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants. AIDS Res Hum Retroviruses 2008; 24:865-72.
21. Ao Z, Huang G, Yao H, et al. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J Biol Chem 2007; 282:13456-67.
22. Dulbecco R. Endpoint methods-measurements of the infectious titer of a viral sample. In: Dulbecco R, Ginsberg HS, eds. Virology. Philadelphia: J. P. Lippincott, 1988:22-5.
23. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856-62.
24. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-77.
25. Eugen-Olsen J, Iversen AK, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997; 11:305-10.
26. Stewart GJ, Ashton LJ, Biti RA, et al. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group. AIDS 1997; 11:1833-8.
27. Paxton WA, Kang S. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 1998; 10:187-94.
28. Brumme ZL, Dong WW, Chan KJ, et al. Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response. AIDS 2003; 17:201-8.
29. Soriano A, Martínez C, García F, et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002; 186:922-31.
30. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 2000; 177:99-111.
31. Chen Y, Mestek A, Liu J, Hurley J A, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 1993; 44:8-12.
32. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature (London) 1997; 386: 499-502.
33. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV- individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000; 287:2274-7.
34. Kwa D, Boeser-Nunnink B, Schuitemaker H. Lack of evidence for an association between a polymorphism in CX3CR1 and the clinical course of HIV infection or virus phenotype evolution. AIDS 2003; 17:759-61.
35. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998; 4:350-3.